Utility of comprehensive genomic profiling (CGP) at an NCI-designated cancer center for identifying clinically relevant genomic alterations (CRGA) and implementing genomically directed therapy (GDT)

Autor:	Jacob Hodskins, Mary Nakazawa, J.R. Vannagell, Philip A. DeSimone, John L. Villano, Aju Mathew, Peng Wang, Ravneet Thind, Edward H. Romond, Mara D. Chambers, Sherry Bayliff, Lars M. Wagner, Talal Hilal, John A. D'Orazio, Tom C. Badgett, Peter J. Hosein, Gaurav Goel, F. Ueland, Susanne M. Arnold, Lowell Anthony
Rok vydání:	2016
Předmět:	0301 basic medicine Oncology Cancer Research medicine.medical_specialty Genomic profiling business.industry Improved survival Cancer medicine.disease 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Refractory 030220 oncology & carcinogenesis Internal medicine Medicine business Empiric therapy
Zdroj:	Journal of Clinical Oncology. 34:e18018-e18018
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2016.34.15_suppl.e18018
Popis:	e18018Background: GDT produces higher response rates and improved survival compared to empiric therapy in some series of patients (pts) with refractory cancers. Limited data exists on the utility o...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::642a770e8e1e78d1509579564d38d630 https://doi.org/10.1200/jco.2016.34.15_suppl.e18018 Zobrazit plný text záznamu